Dr. Jordan Orange Named Pediatrician-in-Chief of NewYork-Presbyterian Morgan Stanley Children’s Hospital and Chair of Pediatrics at Columbia University Vagelos College of Physicians and Surgeons

Jul 3, 2018

New York

Dr. Jordan Orange has been appointed pediatrician-in-chief of NewYork-Presbyterian Morgan Stanley Children’s Hospital and chair of pediatrics at Columbia University Vagelos College of Physicians and Surgeons, effective July 1. Dr. Orange joins from Baylor College of Medicine at Texas Children’s Hospital, where he served as professor and vice chair for research in pediatrics. He succeeds Dr. Lawrence R. Stanberry, who has served as pediatrician-in-chief and chair of pediatrics since 2008.

“We are delighted to welcome Dr. Orange to NewYork-Presbyterian,” said Dr. Steven J. Corwin, president and CEO of NewYork-Presbyterian. “Dr. Orange is an international leader in the field of pediatrics and a renowned researcher who has a deep commitment to caring for patients and their families. We look forward to his leadership at NewYork-Presbyterian Morgan Stanley Children’s Hospital.”

“As one of the nation’s top academic medical centers, we’re committed to delivering outstanding care for our youngest patients and also to pursuing groundbreaking research in children’s health,” said Dr. Lee Goldman, dean of the Faculties of Health Sciences and Medicine at Columbia University and chief executive of Columbia University Irving Medical Center. “Dr. Orange’s exceptional experience as a pediatrician and scientist make him an outstanding choice for this leadership role, and all of us are delighted to welcome him to Columbia.”

As pediatrician-in-chief, Dr. Orange will be responsible for growing NewYork-Presbyterian’s existing pediatric programs — which are ranked among the top in the nation for every pediatric specialty — establishing the hospital as the pre-eminent child health provider in the New York region. Dr. Orange looks forward to creating a stronger presence in the most innovative therapies and personalized medicine in child health. He will also focus on improving the overall patient experience, as well as further expanding the reach of clinical excellence to communities within New York City and in those beyond the city’s limits.

In addition to his commitment to the very best clinical care, Dr. Orange is eager to see the further expansion of child health-oriented research in an effort to develop innovative new treatments for children.

“I am very excited to be joining two institutions that have such an amazing legacy in providing world-class care,” said Dr. Orange. “I’m looking forward to building upon this legacy, to achieve new heights through exceptional clinical care, innovative research, and the education of our future doctors so that the children of New York – of all backgrounds, affected by both simple and complex diseases – receive the best possible treatment and care.”

Dr. Orange has more than 15 years of experience in pediatric immunology and was director of the Pediatrician-Scientist Training and Development Program at Baylor, the Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiency at Texas Children’s Hospital and the Texas Children’s Hospital Center for Human Immunobiology. He also served as the chief of Immunology, Allergy and Rheumatology at Baylor and the Louis and Marybeth Pawelek Endowed Chair at Texas Children’s Hospital. For nearly a decade before moving to Houston in 2012, Dr. Orange served on the faculty of the University of Pennsylvania School of Medicine and held the Jeffrey Modell Endowed Chair for Immunology Research at the Children’s Hospital of Philadelphia.

With an extensive background in pediatric primary immunodeficiency, Dr. Orange has spent much of his career identifying a class of diseases called natural killer cell deficiencies. These diseases impair the immune system’s ability to fight infections and cancer. His research is dedicated to uncovering the cause of these disorders, identifying new diseases and improving diagnosis and treatment for patients. Dr. Orange has been continuously funded by the National Institutes of Health, and has published more than 250 papers.

He is an elected member of the American Society for Clinical Investigation and immediate past president of the Clinical Immunology Society. Dr. Orange has received many awards, including the 2017 E. Mead Johnson Award from the Society for Pediatric Research, one of the highest honors given for child health research, and the 2018 Edith and Peter O’Donnell Award in Medicine from the Texas Academy in Medicine, Engineering and Science for excellence in biomedical research.

Dr. Orange received his bachelor’s degree in biology from Brown University, where he also received his doctorate and medical degrees. After training in pediatrics at Children’s Hospital of Philadelphia, he completed a clinical fellowship in allergy, immunology, and rheumatology at Boston Children’s Hospital and a postdoctoral research fellowship in molecular and cell biology at Harvard.

NewYork-Presbyterian

NewYork-Presbyterian is one of the nation’s most comprehensive, integrated academic healthcare delivery systems, whose organizations are dedicated to providing the highest quality, most compassionate care and service to patients in the New York metropolitan area, nationally, and throughout the globe. In collaboration with two renowned medical schools, Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian is consistently recognized as a leader in medical education, groundbreaking research and innovative, patient-centered clinical care.

NewYork-Presbyterian has four major divisions:

  • NewYork-Presbyterian Hospital is ranked #1 in the New York metropolitan area by U.S. News and World Report and repeatedly named to the Honor Roll of “America’s Best Hospitals.”
  • NewYork-Presbyterian Regional Hospital Network comprises hospitals and other facilities in the New York metropolitan region.
  • NewYork-Presbyterian Physician Services, which connects medical experts with patients in their communities.
  • NewYork-Presbyterian Community and Population Health, encompassing ambulatory care network sites and community healthcare initiatives, including NewYork Quality Care, the Accountable Care Organization jointly established by NewYork-Presbyterian Hospital, Weill Cornell Medicine and Columbia.

For more information, visit www.nyp.org and find us on Facebook, Twitter and YouTube.

Columbia University Irving Medical Center

Columbia University Irving Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the Vagelos College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Irving Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. For more information, visit cuimc.columbia.edu or columbiadoctors.org.

Media Contact:

Alexandra Simpson 212-821-0659